A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Non-Muscle Invasive Bladder Urothelial Carcinoma · Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Arizona Cancer Center - Prevention Research Clinic, Tucson, Arizona, United States

    Contact: Study coordinator (Juan Chipollini) · jchipollini@surgery.arizona.edu · 520-694-4032
    Contact: Principal Investigator (Juan Chipollini)
  • Cedars Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Michael A. Ahdoot) · Michael.Ahdoot@cshs.org · 310-423-2659
    Contact: Principal Investigator (Michael A. Ahdoot)
  • National Cancer Institute Urologic Oncology Branch, Bethesda, Maryland, United States

    Contact: Study coordinator (Sandeep Gurram) · Sandeep.Gurram@nih.gov · 240-858-3700
    Contact: Principal Investigator (Sandeep Gurram)
  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Edward M. Messing) · edward_messing@urmc.rochester.edu · 585-275-3345
    Contact: Principal Investigator (Edward M. Messing)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Debasish Sundi) · D.Sundi@osumc.edu · 219-713-9783
    Contact: Principal Investigator (Debasish Sundi)
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

    Contact: Study coordinator (Kyle A. Richards) · richardsk@urology.wisc.edu · 608-262-0759
    Contact: Principal Investigator (Kyle A. Richards)
Study leads
  • Edward M Messing

    Principal Investigator

    University of Wisconsin, Madison